Stratified medicine for mental disorders

European Neuropsychopharmacology

Volumn 24, Issue 1, 2014, Pages 5-50

  Schumann, Gunter ^a   Binder, Elisabeth B ^b   Holte, Arne ^c   de Kloet, E Ronald ^d   Oedegaard, Ketil J ^e   Robbins, Trevor W ^f   Walker Tilley, Tom R ^a   Bitter, Istvan ^aj   Brown, Verity J ^g   Buitelaar, Jan ^h   Ciccocioppo, Roberto ⁱ   Cools, Roshan ^j   Escera, Carles ^k   Fleischhacker, Wolfgang ^l   Flor, Herta ^m   Frith, Chris D ⁿ   Heinz, Andreas ^o   Johnsen, Erik ^e   Kirschbaum, Clemens ^p   Klingberg, Torkel ^q   Lesch, Klaus Peter ^r   Lewis, Shon ^s   Maier, Wolfgang ^t   Mann, Karl ^u   Martinot, Jean Luc ^v,w   Meyer Lindenberg, Andreas ^m   Müller, Christian P ^x   Müller, Walter E ^y   Nutt, David J ^z   Persico, Antonio ^aa   Perugi, Giulio ^ab   Pessiglione, Mathias ^ac   Preuss, Ulrich W ^ad   Roiser, Jonathan P ^ae   Rossini, Paolo M ^af   Rybakowski, Janusz K ^ag   Sandi, Carmen ^ah   Stephan, Klaas E ^ai   Undurraga, Juan ^ai   Vieta, Eduard ^k   van der Wee, Nic ^d   Wykes, Til ^a   Haro, Josep Maria ^k   Wittchen, Hans Ulrich ^p   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BERGEN   (Norway)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF ST ANDREWS   (United Kingdom)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF CAMERINO   (Italy)

^j Donders Institute   (Netherlands)

^k UNIVERSITY OF BARCELONA   (Spain)

^l INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^m MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^q KAROLINSKA INSTITUTE   (Sweden)

^r UNIVERSITY OF WÜRZBURG   (Germany)

^s UNIVERSITY OF MANCHESTER   (United Kingdom)

^t UNIVERSITY OF BONN   (Germany)

^u CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^v INSERM   (France)

^w ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^x UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^y GOETHE UNIVERSITY   (Germany)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^ab UNIVERSITY OF PISA   (Italy)

^ac PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ad MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^ae UNIVERSITY COLLEGE LONDON   (United Kingdom)

^af FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^ag POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^ah EPFL   (Switzerland)

^ai UNIVERSITY OF ZURICH   (Switzerland)

^aj SEMMELWEIS UNIVERSITY   (Hungary)

more..

Author keywords

Mental disorder; Neural processes; Psychopathology; Roadmap; Stratified medicine; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CLOZAPINE; METABOTROPIC RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OXYTOCIN; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AFFECT; ANXIETY DISORDER; AROUSAL; ATTENTION; AUTISM; BASIC RESEARCH; BIOMEDICINE; BIPOLAR DISORDER; BRAIN; BRAIN ELECTROPHYSIOLOGY; CHOLINERGIC SYSTEM; CHRONIC STRESS; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COGNITION; COMORBIDITY; CONCEPTUAL FRAMEWORK; COPING BEHAVIOR; DECISION MAKING; DEPRESSION; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; EMOTION; EMPATHY; EXECUTIVE FUNCTION; EYE; FACIAL EXPRESSION; FUNCTIONAL NEUROIMAGING; GAZE; GENOTYPE PHENOTYPE CORRELATION; HABIT; HEALTH; HEALTH CARE ORGANIZATION; HEARING; HUMAN; IMITATION; LANGUAGE; LIGHT DARK CYCLE; LONG TERM MEMORY; MEDIATOR; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH RESEARCH; MENTAL PATIENT; MOOD DISORDER; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROSCIENCE; NONHUMAN; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGY; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PUBLIC HEALTH; PUNISHMENT; REINFORCEMENT; REVIEW; REWARD; RISK FACTOR; SCHIZOPHRENIA; SLEEP WAKING CYCLE; SOCIAL ASPECT; STRESS; TACTILE STIMULATION; THREAT; TOUCH; TOUCH THERAPY; WELLBEING; WORKING MEMORY;

MENTAL DISORDER; NEURAL PROCESSES; PSYCHOPATHOLOGY; ROADMAP; STRATIFIED MEDICINE; TREATMENT;

BIOMEDICAL RESEARCH; BRAIN; EUROPE; HUMANS; INDIVIDUALIZED MEDICINE; MENTAL DISORDERS;

EID: 84892623734     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.09.010     Document Type: Review

References (285)

1. Abu-Akel A., Shamay-Tsoory S. Neuroanatomical and neurochemical bases of theory of mind. Neuropsychologia 2011, 49:2971-2984.
2. Adams C. Practitioner review: the assessment of language pragmatics. Journal of Child Psychology and Psychiatry 2002, 43:973-987.
3. Adolphs R. Recognising emotion from facial expressions: psychological and neurological mechanisms. Behavioural and Cognitive Neuroscience Reviews 2002, 1:21-62.
4. Adolphs R. Cognitive neuroscience of human social behaviour. Nature Reviews Neuroscience 2003, 4:165-178.
5. Akil H., Martone M.E., Van Essen D.C. Challenges and opportunities in mining neuroscience data. Science 2011, 331:708-712.
6. Alcaro A., Panksepp J. Neuroscience & Biobehavioral Reviews 2011, 35(9):1805-1820.
7. Andreassen O.A., Djurovic S., Thompson W.K., Schork A.J., Kendler K.S., O'Donovan M.C., Rujescu D., Werge T., van de Bunt M., Morris A.P., McCarthy M.I., International Consortium for Blood Pressure GWAS, Diabetes Genetics Replication and Meta-analysis Consortium, Psychiatric Genomics Consortium Schizophrenia Working Group, Roddey J.C., McEvoy L.K., Desikan R.S., Dale A.M. American Journal of Human Genetics 2013, 92:197-209.
8. Anon A decade for psychiatric disorders. Nature 2010, 463:9.
9. Attwood B.K., Bourgognon J.M., Patel S., Mucha M., Schiavon E., Skrzypiec A.E., Young K.W., Shiosaka S., Korostynski M., Piechota M., Przewlocki R., Pawlak R. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 2011, 473:372-375.
10. Atzil S., Hendler T., Feldman R. Specifying the neurobiological basis of human attachment: brain, hormones, and behaviour in synchronous and intrusive mothers. Neuropsychopharmacology 2011, 36:2603-2615.
11. Averbeck B.B., Evans S., Chouhan V., Bristow E., Shergill S.S. Probabilistic learning and inference in schizophrenia. Schizophrenia Research 2011, 127:115-122.
12. Baird A.D., Scheffer I.E., Wilson S.J. Mirror neuron system involvement in empathy: a critical look at the evidence. Society for Neuroscience 2011, 6:327-335.
13. Bakeman R., Adamson L.B. Coordinating attention to people and objects in mother-infant and peer-infant interaction. Child Development 1984, 55:1278-1289.
14. Barr C.S., Newman T.K., Becker M.L., Parker C.C., Champoux M., Lesch K.P., Goldman D., Suomi S.J., Higley J.D. The utility of the non-human primate; model for studying gene by environment interactions in behavioural research. Genes, Brain & Behaviour 2003, 2:336-340.
15. Bassareo V., Di Chiara G. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. Journal of Neuroscience 1997, 17:851-861.
16. Bassareo V., Di Chiara G. Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. European Journal of Neuroscience 1999, 11:4389-4397.
17. Behrens T.E.J., Woolrich M.W., Walton M.E., Rushworth M.F.S. Learning the value of information in an uncertain world. Nature Neuroscience 2007, 10:1214-1221.
18. Belin D., Everitt B.J. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008, 57:432-441.
19. Bell, C., 2011. The Healing Properties of Touch Associated with Premature Infants and Childhood Development: A Literature Review. Logan College of Chiropractic. Available from: http://www.logan.edu/mm/files/LRC/Senior-Research/2011-Aug-04.pdf.
20. Berridge K.C. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berlin) 2007, 191:391-431.
21. Berton O., Hahn C.G., Thase M.E. Are we getting closer to valid translational models for major depression?. Science 2012, 338:75-79.
22. Binder E.B., Holsboer F. Low cortisol and risk and resilience to stress-related psychiatric disorders. Biological Psychiatry 2012, 71:282-283.
23. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics 2001, 69:89-95.
24. Blair R.J. Facial expressions, their communicatory functions and neuro-cognitive substrates. Philosophical Transactions of the Royal Society of London B: Biological Sciences 2003, 358:561-572.
25. Blair R.J. Responding to the emotions of others: dissociating forms of empathy through the study of typical and psychiatric populations. Consciousness and Cognition 2005, 14:698-718.
26. Brischoux F., Chakraborty S., Brierley D.I., Ungless M.A. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:4894-4899.
27. Brodersen K.H., Schofield T.M., Leff A.P., Ong C.S., Lomakina E.I., Buhmann J.M., Stephan K.E. Generative embedding for model-based classification of fMRI data. PLOS Computational Biology 2011, 7:e1002079.
28. Broich K., Möller H.J. Pharmacogenetics, pharmacogenomics and personalised psychiatry: are we there yet?. European Archives of Psychiatry and Clinical Neuroscience 2008, 258(Suppl 1):1-2.
29. Broich K., Weiergräber M., Hampel H. Biomarkers in clinical trials for neurodegenerative diseases: regulatory perspectives and requirements. Progress in Neurobiology 2011, 95:498-500.
30. Campayo A., de Jonge P., Roy J.F., Saz P., de la Cámara C., Quintanilla M.A., Marcos G., Santabarbara J., Lobo A. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. American Journal of Psychiatry 2010, 167:580-588.
31. Campayo A., de Jonge P., Roy J.F., Saz P., de la Cámara C., Quintanilla M.A., Marcos G. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. The American Journal of Psychiatry 2010, 167(5):580-588.
32. Canli T., Lesch K.P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nature Neuroscience 2007, 10:1103-1109. http://www.ncbi.nlm.nih.gov/pubmed/17726476.
33. Carola V., Gross C. Mouse models of the 5-HTTLPR x stress risk factor for depression. Current Topics in Behavioural Neurosciences 2012, 12:59-72.
34. Carpenter W.T., Davis J.M. Another view of the history of antipsychotic drug discovery and development. Molecular Psychiatry 2012, 17:1168-1173.
35. Carter C.S., Barch D.M. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophrenia Bulletin 2007, 33:1131-1137.
36. Castner S.A., Williams G.V. Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain and Cognition 2007, 63:94-122.
37. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behaviour. Science 2006, 314:140-143.
38. Cookson J., Hodgson R., Wildgust H.J. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis. Journal of Psychopharmacology 2012, 26:42-51.
39. Corbett B.A., Carmean V., Ravizza S., Wendelken C., Henry M.L., Carter C., Rivera S.M. A functional and structural study of emotion and face processing in children with autism. Psychiatry Research 2009, 173:196-205.
40. Covington H.E., Maze I., LaPlant Q.C., Vialou V.F., Ohnishi Y.N., Berton O., Fass D.M., Renthal W., Rush A.J., Wu E.Y., Ghose S., Krishnan V., Russo S.J., Tamminga C., Haggarty S.J., Nestler E.J. Antidepressant actions of histone deacetylase inhibitors. Journal of Neuroscience 2009, 29:11451-11460.
41. Csete M., Doyle J. Bow ties, metabolism and disease. Trends in Biotechnology 2004, 22:446-450.
42. Dayalu P., Chou K.L. Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opinion on Pharmacotherapy 2008, 9:1451-1462.
43. De Hert M., Correll C.U., Bobes J., Cetkovich-Bakmas M., Cohen D., Asai I., Detraux J., Gautam S., Möller H.J., Ndetei D.M., Newcomer J.W., Uwakwe R., Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011, 10:52-77.
44. De Hert M., Dekker J.M., Wood D., Kahl K.G., Holt R.I., Moller H.J. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 2009, 24:412-424.
45. de Kloet E.R., Joëls M., Holsboer F. Stress and the brain: from adaptation to disease. Nature Reviews Neuroscience 2005, 6:463-475.
46. Decety J., Jackson P.L. The functional architecture of human empathy. Behavioural and Cognitive Neuroscience Reviews 2004, 3:71-100.
47. Decety J., Moriguchi Y. The empathic brain and its dysfunction in psychiatric populations: implications for intervention across different clinical conditions. BioPsychoSocial Medicine 2007, 1:22.
48. Deisseroth K. Optogenetics and psychiatry: applications, challenges, and opportunities. Biological Psychiatry 2012, 71:1030-1032.
49. denOuden H.E.M., Daunizeau J., Roiser J., Friston K.J., Stephan K.E. Striatal prediction error modulates cortical coupling. Journal of Neuroscience 2010, 30:3210-3219.
50. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., Costa R.M., Sousa N. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
51. Dunbar R.I. The social role of touch in humans and primates: behavioural function and neurobiological mechanisms. Neuroscience & Biobehavioral Reviews 2010, 34:260-268.
52. Egede L.E. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. General Hospital Psychiatry 2007, 29:409-416.
53. Eichenbaum H., Yonelinas A.P., Ranganath C. The medial temporal lobe and recognition memory. Annual Review of Neuroscience 2007, 30:123-152.
54. Elliott R., Dolan R.J., Frith C.D. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cerebral Cortex 2000, 10:308-317.
55. Eroglu C., Barres B.A. Regulation of synaptic connectivity by glia. Nature 2010, 468:223-231.
56. Eshel N., Roiser J.P. Reward and punishment processing in depression. Biological Psychiatry 2010, 68:118-124.
57. Etkin A., Wager T.D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry 2007, 164:1476-1488.
58. European Commission Horizon 2020, (accessed2.05.13). Available from: http://www.ec.europa.eu/research/horizon2020.
59. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience 2005, 8:1481-1489.
60. Everson S.A., Roberts R.E., Goldberg D.E., Kaplan G.A. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Archives of Internal Medicine 1998, 158:1133-1138.
61. Fair D.A., Cohen A.L., Dosenbach N.U.F., Church J.A., Miezin F.M., Barch D.M., Raichle M.E., Petersen S.E., Schlaggar B.L. The maturing architecture of the brain's default network. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4028-4032.
62. Faure A., Haberland U., Conde F., El M.N. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. Journal of Neuroscience 2005, 25:2771-2780.
63. Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003, 53:649-659.
64. Feinstein A.R. The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases 1970, 23:455-468.
65. Field T., Diego M., Hernandez-Reif M., Dieter J.N., Kumar A.M., Schanberg S., Kuhn C. Insulin and insulin-like growth factor-1 increased in preterm neonates following massage therapy. Journal of Developmental and Behavioural Pediatrics 2008, 29:463-466.
66. Figueira M.L., Brissos S. Measuring psychosocial outcomes in schizophrenia patients. Current Opinion in Psychiatry 2011, 24:91-99.
67. Fingelkurts A.A., Fingelkurts A.A., Bagnato S., Boccagni C., Galardi G. DMN operational synchrony relates to self-consciousness: evidence from patients in vegetative and minimally conscious states. Open Neuroimaging Journal 2012, 6:55-68.
68. Encyclopedia of Stress 2007, Elsevier, Oxford. 2nd Ed. G. Fink (Ed.).
69. Fitzsimons C.P., van Hooijdonk L.W., Schouten M., Zalachoras I., Brinks V., Zheng T., Schouten T.G., Saaltink D.J., Dijkmans T., Steindler D.A., Verhaagen J., Verbeek F.J., Lucassen P.J., de Kloet E.R., Meijer O.C., Karst H., Joels M., Oitzl M.S., Vreugdenhil E. Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior. Molecular Psychiatry 2013, 18:993-1005. http://www.ncbi.nlm.nih.gov/pubmed/22925833.
70. Fleischhacker W.W., Cetkovich-Bakmas M., De Hert M., Hennekens C.H., Lambert M., Leucht S., Maj M., McIntyre R.S., Naber D., Newcomer J.W., Olfson M., Osby U., Sartorius N., Lieberman J.A. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. Journal of Clinical Psychiatry 2008, 69:514-519.
71. Fleischhacker W.W., Rabinowitz J., Kemmler G., Eerdekens M., Mehnert A. Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. British Journal of Psychiatry 2005, 187:131-136.
72. Fleischhacker W.W., Uchida H. Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. International Journal of Neuropsychopharmacology 2012, 1-11.
73. Fletcher P.C., Frith C.D. Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nature Reviews Neuroscience 2008, 10:48-58.
74. Foley P., Kirschbaum C. Human hypothalamus-pituitary-adrenal axis responses to acute psychosocial stress in laboratory settings. Neuroscience & Biobehavioral Reviews 2010, 35:91-96.
75. Fornito A., Bullmore E.T. Connectomic intermediate phenotypes for psychiatric disorders. Frontiers in Psychiatry 2012, 3:32.
76. Fowler C.D., Lu Q., Johnson P.M., Marks M.J., Kenny P.J. Habenular α5* nicotinic receptor signalling controls nicotine intake. Nature 2011, 471:597-601.
77. Frank M.J., Badre D. Mechanisms of hierarchical reinforcement learning in corticostriatal circuits 1: computational analysis. Cerebral Cortex 2011, 22:509-526.
78. Friston K.J., Harrison L., Penny W. Dynamic causal modelling. Neuroimage 2003, 19:1273-1302.
79. Frith C. Explaining delusions of control: the comparator model 20 years on. Consciousness and Cognition 2012, 21:52-54.
80. Gallace A., Spence C. The science of interpersonal touch: an overview. Neuroscience & Biobehavioral Reviews 2010, 34:246-259.
81. Gallese V., Fadiga L., Fogassi L., Rizzolatti G. Action recognition in the premotor cortex. Brain 1996, 119:593-609.
82. Gazzola V., Spezio M.L., Etzel J.A., Castelli F., Adolphs R., Keysers C. Primary somatosensory cortex discriminates affective significance in social touch. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:E1657-E1666.
83. Gelenberg A.J., Chesen C.L. How fast are antidepressants?. The Journal of Clinical Psychiatry 2000, 61:712-721.
84. Geschwind D.H., Konopka G. Neuroscience in the era of functional genomics and systems biology. Nature 2009, 461:908-915.
85. Glimcher P.W., Camerer C., Poldrack R.A., Rangel A., Fehr E. Neuroeconomics: Decision Making and the Brain 2008, Academic Press, Waltham. First ed.
86. Goldberg D. The detection and treatment of depression in the physically ill. World Psychiatry 2010, 9:16-20.
87. Grace A.A. Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotoxicity Research 2010, 18:367-376.
88. Graeber M.B. Changing face of microglia. Science 2010, 330:783-788.
89. Gustavsson A., Svensson M., Jacobi F., Allgulander C., Alonso J., Beghi E., Dodel R., Ekman M., Faravelli C., Fratiglioni L., Gannon B., Jones D.H., Jennum P., Jordanova A., Jönsson L., Karampampa K., Knapp M., Kobelt G., Kurth T., Lieb R., Linde M., Ljungcrantz C., Maercker A., Melin B., Moscarelli M., Musayev A., Norwood F., Preisig M., Pugliatti M., Rehm J., Salvador-Carulla L., Schlehofer B., Simon R., Steinhausen H.-C., Stovner L.J., Vallat J.-M., den Bergh P.V., van Os J., Vos P., Xu W., Wittchen H.-U., Jönsson B., Olesen J., CDBE2010 Study Group Cost of disorders of the brain in Europe 2010. European Neuropsychopharmacology 2011, 21:718-779.
90. Haans A., IJsselsteijn W. Mediated social touch: a review of current research and future directions. Virtual Reality 2005, 9:149-159.
91. Haber S.N., Fudge J.L., McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. Journal of Neuroscience 2000, 20:2369-2382.
92. Hagoort P. On Broca, brain, and binding: a new framework. Trends in Cognitive Sciences 2005, 9:416-423.
93. Haramati S., Navon I., Issler O., Ezra-Nevo G., Gil S., Zwang R., Hornstein E., Chen A. MicroRNA as respressors of stress induced anxiety: the case of amydalar miR-34. Journal of Neuroscience 2011, 31:14191-14203.
94. Härter M.C., Conway K.P., Merikangas K.R. Associations between anxiety disorders and physical illness. European Archives of Psychiatry and Clinical Neuroscience 2003, 253:313-320.
95. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia - psychopathological and behavioural correlates. European Psychiatry 2002, 17:9-16.
96. Heinz A., Reimold M., Wrase J., Hermann D., Croissant B., Mundle G., Dohmen B.M., Braus D.F., Schumann G., Machulla H.J., Bares R., Mann K. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labelled carfentanil. Archives of General Psychiatry 2005, 62:57-64.
97. Hellhammer D., Hero T., Gerhards F., Hellhammer J. Neuropattern: a new translational tool to detect and treat stress pathology I. Strategical consideration. Stress 2012, 15:479-487.
98. Herman J.P. Neural control of chronic stress adaptation. Frontiers in Behavioral Neuroscience 2013, 7:61. http://www.ncbi.nlm.nih.gov/pubmed/23964212.
99. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Frontiers in Neuroendocrinology 2003, 24:151-180.
100. Hollerman J.R., Schultz W. Dopamine neurons report an error in the temporal prediction of reward during learning. Nature Neuroscience 1998, 1:304-309.
101. Holsboer F., Ising M. Stress hormone regulation: biological role and translation into therapy. Annual Review of Psychology 2010, 61:81-109.
102. Hovelsø N., Sotty F., Montezinho L.P., Pinheiro P.S., Herrik K.F., Mork A. Therapeutic potential of metabotropic glutamate receptor modulators. Current Neuropharmacology 2012, 10:12-48.
103. Hu X., Wang J., Dong W., Fang Q., Hu L., Liu C. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Research 2011, 97:73-82.
104. Huber R., Panksepp J.B., Nathaniel T., Alcaro A., Panksepp J. Drug-sensitive reward in crayfish: an invertebrate model system for the study of seeking, reward, addiction, and withdrawal. Neuroscience & Biobehavioral Reviews 2011, 35:1847-1853.
105. Huston J.P., Silva M.A., Komorowski M., Schulz D., Topic B. Animal models of extinction-induced depression: loss of reward and its consequences. Neurosci. & Biobehav. Rev. 2013, S0149-7634(13):52-53. (Epub ahead of print).
106. Huys Q.J.M., Cools R., Gölzer M., Friedel E., Heinz A., Dolan R.J., Dayan P. Disentangling the roles of approach, activation and valence in instrumental and Pavlovian responding. PLOS Computational Biology 2011, 7:e1002028.
107. Iacoviello B.M., Alloy L.B., Abramson L.Y., Choi J.Y. The early course of depression: a longitudinal investigation of prodromal symptoms and their relation to the symptomatic course of depressive episodes. Journal of Abnormal Psychology 2010, 119:459-467.
108. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behaviour: a unifying interpretation with special reference to reward-seeking. Brain Research Reviews 1999, 31:6-41.
109. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 2010, 167:748-751.
110. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
111. Ishak W.W., Kahloon M., Fakhry H. Oxytocin role in enhancing well-being: a literature review. Journal of Affective Disorders 2011, 130:1-9.
112. Ising M., Künzel H.E., Binder E.B., Nickel T., Modell S., Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005, 29:1085-1093.
113. Jaeggi S.M., Buschkuehl M., Jonides J., Perrig W.J. Improving fluid intelligence with training on working memory. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6829-6833.
114. Jakovljević M., Reiner Z., Milicić D., Crncević Z. Comorbidity, multimorbidity and personalised psychosomatic medicine: epigenetics rolling on the horizon. Psychiatria Danubina 2010, 22:184-189.
115. Jardri R., Houfflin-Debarge V., Delion P., Pruvo J.-P., Thomas P., Pins D. Assessing fetal response to maternal speech using a noninvasive functional brain imaging technique. International Journal of Developmental Neuroscience 2012, 30:159-161.
116. Joëls M., Baram T.Z. The neuro-symphony of stress. Nature Reviews Neuroscience 2009, 10:459-466.
117. Joëls M., Sarabdjitsingh R.A., Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacological Reviews 2012, 64:901-938.
118. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. Journal of Physiology 1992, 450:455-468. http://www.ncbi.nlm.nih.gov/pubmed/1331427.
119. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988, 45:789-796.
120. Kapur S., Phillips A.G., Insel T.R. Why has it taken so long for biological psychiatry to develop clinical tests, and what to do about it. Molecular Psychiatry 2012, 17:1174-1179.
121. Katschnig H. Quality of life in mental disorders: challenges for research and clinical practice. World Psychiatry 2006, 5:139-145.
122. Kaun K.R., Azanchi R., Maung Z., Hirsh J., Heberlein U. A Drosophila model for alcohol reward. Nature Neuroscience 2011, 14:612-619.
123. Kendler K.S., Gardner C.O., Fiske A., Gatz M. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Archives of General Psychiatry 2009, 66:857-863.
124. Kerwin R.W. Management of clozapine-resistant schizophrenia. Advances in Psychiatric Treatment 2005, 11:101-106.
125. Kessler R.C., Amminger G.P., Aguilar-Gaxiola S., Alonso J., Lee S., Ustun T.B. Age of onset of mental disorders: a review of recent literature. Current Opinion in Psychiatry 2007, 20:359-364.
126. Klingberg T. Training and plasticity of working memory. Trends in Cognitive Sciences 2010, 14:317-324.
127. Klok M.D., Giltay E.J., Van der Does A.J.W., Geleijnse J.M., Antypa N., Penninx B.W.J.H., de Geus E.J.C., Willemsen G., Boomsma D.I., van Leeuwen N., Zitman F.G., de Kloet E.R., DeRijk R.H. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Translational Psychiatry 2011, 1:e62.
128. Koolhaas J.M., Bartolomucci A., Buwalda B., de Boer S.F., Flügge G., Korte S.M., Meerlo P., Murison R., Olivier B., Palanza P., Richter-Levin G., Sgoifo A., Steimer T., Stiedl O., van Dijk G., Wöhr M., Fuchs E. Stress revisited: a critical evaluation of the stress concept. Neuroscience & Biobehavioral Reviews 2011, 35:1291-1301.
129. Krishnadas R., Cavanagh J. Depression: an inflammatory illness?. Journal of Neurology, Neurosurgery, and Psychiatry 2012, 83:495-502.
130. Kroch S., Kamenczak A., Chrostek Maj J., Polewka A. Somatic and psychiatric disorders in alcohol-addicted patients treated in a detoxification unit. Przeglad Lekarski 2004, 61:300-302.
131. Kupfer D.J., Frank E., Phillips M.L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012, 379:1045-1055.
132. Lammel S., Ion D.I., Roeper J., Malenka R.C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 2011, 70:855-862.
133. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., Deisseroth K., Malenka R.C. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
134. Laursen T.M., Munk-Olsen T., Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS ONE 2011, 6:e24597.
135. Lazarus J.H. Lithium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism 2009, 23:723-733.
136. Lazarus R.S. Emotions and interpersonal relationships: toward a person-centered conceptualization of emotions and coping. Journal of Personality 2006, 74:9-46.
137. Le Moal M., Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology 2007, 17:377-393.
138. Leboyer M., Soreca I., Scott J., Frye M., Henry C., Tamouza R., Kupfer D.J. Can bipolar disorder be viewed as a multi-system inflammatory disease?. Journal of Affective Disorders 2012, 141:1-10.
139. Ledford J.R., Wolery M. Teaching imitation to young children with disabilities: a review of the literature. Topics in Early Childhood Special Education 2010, 30:245-255.
140. Lemche E., Giampietro V.P., Surguladze S.A., Amaro E.J., Andrew C.M., Williams S.C.R., Brammer M.J., Lawrence N., Maier M.A., Russell T.A., Simmons A., Ecker C., Joraschky P., Phillips M.L. Human attachment secruity is mediated by the amydala: Evidence from combines fMRI and psychophysiological measures. Human Brain Mapping 2006, 27(8):623-635.
141. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. The Lancet 2009, 373:31-41.
142. Leucht S., Hierl S., Kissling W., Dold M., Davis J.M. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. British Journal of Psychiatry 2012, 200:97-106.
143. Leucht S., Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006, 39:161-170.
144. Levine S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology 2005, 30:939-946.
145. Lightman S.L., Conway-Campbell B.L. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nature Reviews Neuroscience 2010, 11:710-718.
146. Littlejohn S.W., Foss K.A. Theories of Human Communication 2011, Waveland Press, Long Grove, Ill. 10th ed.
147. Liu J.Z., Tozzi F., Waterworth D.M., Pillai S.G., Muglia P., Middleton L., Berrettini W., Knouff C.W., Yuan X., Waeber G., Vollenweider P., Preisig M., Wareham N.J., Zhao J.H., Loos R.J.F., Barroso I., Khaw K.-T., Grundy S., Barter P., Mahley R., Kesaniemi A., McPherson R., Vincent J.B., Strauss J., Kennedy J.L., Farmer A., McGuffin P., Day R., Matthews K., Bakke P., Gulsvik A., Lucae S., Ising M., Brueckl T., Horstmann S., Wichmann H.E., Rawal R., Dahmen N., Lamina C., Polasek O., Zgaga L., Huffman J., Campbell S., Kooner J., Chambers J.C., Burnett M.S., Devaney J.M., Pichard A.D., Kent K.M., Satler L., Lindsay J.M., Waksman R., Epstein S., Wilson J.F., Wild S.H., Campbell H., Vitart V., Reilly M.P., Li M., Qu L., Wilensky R., Matthai W., Hakonarson H.H., Rader D.J., Franke A., Wittig M., Schäfer A., Uda M., Terracciano A., Xiao X., Busonero F., Scheet P., Schlessinger D., Clair D.S., Rujescu D., Abecasis G.R., Grabe H.J., Teumer A., Völzke H., Petersmann A., John U., Rudan I., Hayward C., Wright A.F., Kolcic I., Wright B.J., Thompson J.R., Balmforth A.J., Hall A.S., Samani N.J., Anderson C.A., Ahmad T., Mathew C.G., Parkes M., Satsangi J., Caulfield M., Munroe P.B., Farrall M., Dominiczak A., Worthington J., Thomson W., Eyre S., Barton A., Wellcome Trust Case Control Consortium, Mooser V., Francks C., Marchini J. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics 2010, 42:436-440.
148. Lopez-Munoz F., Baumeister A.A., Hawkins M.F., Alamo C. The role of serendipity in the discovery of the clinical effects of psychotropic drugs: beyond of the myth. Actas Españolas de Psiquiatría 2012, 40:34-42.
149. Loth E., Carvalho F., Schumann G. The contribution of imaging genetics to the development of predictive markers for addictions. Trends in Cognitive Sciences 2011, 15:436-446.
150. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress
151. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., Zitman F.G. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry 2010, 67:220-229.
152. Lutter M., Nestler E.J. Homeostatic and hedonic signals interact in the regulation of food intake. Journal of Nutrition 2009, 139:629-632.
153. Mahon B.Z., Caramazza A. A critical look at the embodied cognition hypothesis and a new proposal for grounding conceptual content. Journal of Physiology (Paris) 2008, 102:59-70.
154. Mana S., Paillère Martinot M.L., Martinot J.L. Brain imaging findings in children and adolescents with mental disorders: a cross-sectional review. European Psychiatry 2010, 25:345-354.
155. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 2005, 62:975-983.
156. Martinot M.-L.P., Bragulat V., Artiges E., Dollé F., Hinnen F., Jouvent R., Martinot J.-L. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. American Journal of Psychiatry 2001, 158:314-316.
157. Mathys C. A Bayesian foundation for individual learning under uncertainty. Frontiers in Human Neuroscience 2011, 5:39.
158. McClure E.B., Monk C.S., Nelson E.E., Zarahn E., Leibenluft E., Bilder R.M., Charney D.S., Ernst M., Pine D.S. A developmental examination of gender differences in brain engagement during evaluation of threat. Biological Psychiatry 2004, 55:1047-1055.
159. McEwen B.S., Gianaros P.J. Stress- and allostasis-induced brain plasticity. Annual Review of Medicine 2011, 62:431-445.
160. McEwen B.S., Stellar E. Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine 1993, 153:2093-2101.
161. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T., Woods S.W., Hawkins K.A., Hoffman R.E., Preda A., Epstein I., Addington D., Lindborg S., Trzaskoma Q., Tohen M., Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry 2006, 163:790-799.
162. McGlone F., Vallbo A.B., Olausson H., Loken L., Wessberg J. Discriminative touch and emotional touch. Canadian Journal of Experimental Psychology 2007, 61:173-183.
163. McGowan P.O., Suderman M., Sasaki A., Huang T.C., Hallett M., Meaney M.J., Szyf M. Broad epigenetic signature of maternal care in the brain of adult rats. PLoS One 2011, 6:e14739.
164. McWilliams L.A., Goodwin R.D., Cox B.J. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004, 111:77-83.
165. Meaney M.J. Epigenetics and the Biological definition of gene×environment interactions. Child Development 2010, 81:41-79.
166. Mellon N.K., Ouellette M., Greer T., Gates-Ulanet P. Achieving developmental synchrony in young children with hearing loss. Trends in Amplification 2009, 13:223-240.
167. Mendelson J.H., Babor T.F., Mello N.K., Pratt H. Alcoholism and prevalence of medical and psychiatric disorders. Journal of Studies on Alcohol 1986, 47:361-366.
168. Menke A., Klengel T., Rubel J., Brückl T., Pfister H., Lucae S., Uhr M., Holsboer F., Binder E.B. Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes, Brain and Behaviour 2013, 12:289-296.
169. Meyer-Lindenberg A. From maps to mechanisms through neuroimaging of schizophrenia. Nature 2010, 468:194-202.
170. Millan M.J., Agid Y., Brune M., Bullmore E.T., Carter C.S., Clayton N.S., Connor R., Davis S., Deakin B., DeRubeis R.J., Dubois B., Geyer M.A., Goodwin G.M., Gorwood P., Jay T.M., Joels M., Mansuy I.M., Meyer-Lindenberg A., Murphy D., Rolls E., Saletu B., Spedding M., Sweeney J., Whittington M., Young L.J. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews Drug Discovery 2012, 11:141-168.
171. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
172. Milton A.L., Everitt B.J. The psychological and neurochemical mechanisms of drug memory reconsolidation: implications for the treatment of addiction. European Journal of Neuroscience 2010, 31:2308-2319.
173. Molenberghs P., Cunnington R., Mattingley J.B. Is the mirror neuron system involved in imitation? A short review and meta-analysis. Neuroscience & Biobehavioral Reviews 2009, 33:975-980.
174. Moore H., Jentsch J.D., Ghajarnia M., Geyer M.A., Grace A.A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biological Psychiatry 2006, 60:253-264.
175. Mors O., Mortensen P.B., Ewald H. A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophrenia Research 1999, 40:67-74.
176. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
177. Müller M.B., Holsboer F. Mice with mutations in the HPA-system as models for symptoms of depression. Biological Psychiatry 2006, 59:1104-1115.
178. Munafò M.R., Araya R. Cigarette smoking and depression: a question of causation. British Journal of Psychiatry 2010, 196:425-426.
179. Murgatroyd C., Spengler D. Genetic variation in the epigenetic machinery and mental health. Current Psychiatry Report 2012, 14:138-149.
180. Murray G.K., Corlett P.R., Clark L., Pessiglione M., Blackwell A.D., Honey G., Jones P.B., Bullmore E.T., Robbins T.W., Fletcher P.C. Substantianigra/ventral tegmental reward prediction error disruption in psychosis. Molecular Psychiatry 2007, 13:267-276.
181. Murrough J.W., Charney D.S. Is there anything really novel on the antidepressant horizon?. Current Psychiatry Reports 2012, 14:643-649.
182. Näätänen R., Kujala T., Kreegipuu K., Carlson S., Escera C., Baldeweg T., Ponton C. The mismatch negativity: an index of cognitive decline in neuropsychiatric and neurological diseases and in ageing. Brain 2011, 134:3435-3453.
183. Naber F.B.A., Poslawsky I.E., van IJzendoorn M.H., van Engeland H., Bakermans-Kranenburg M.J. Brief report: oxytocin enhances paternal sensitivity to a child with autism: a double-blind within-subject experiment with intranasally administered oxytocin. Journal of Autism and Developmental Disorders 2012, 43:224-229.
184. National Institute for Health and Clinical Excellence, 2009. CG90 Depression in adults: The Treatment and Management of Depression in Adults. Available from: http://publications.nice.org.uk/depression-in-adults-cg90/.
185. Nederhof E., Schmidt M.V. Mismatch or cumulative stress: toward an integrated hypothesis of programming effects. Physiology & Behaviour 2012, 106:691-700.
186. NEWMEDS - The NEWMEDS Project, accessed 7.05.. Available from: http://www.newmeds-europe.com.
187. Noonan M.P., Kolling N., Walton M.E., Rushworth M.F.S. Re-evaluating the role of the orbitofrontal cortex in reward and reinforcement. European Journal of Neuroscience 2012, 35:997-1010.
188. Nunes E.V., Rounsaville B.J. Comorbidity of substance use with depression and other mental disorders: from diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) to DSM-V. Addiction 2006, 101:89-96.
189. Nutt D., Demyttenaere K., Janka Z., Aarre T., Bourin M., Canonico P.L., Carrasco J.L., Stahl S. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. Journal of Psychopharmacology (Oxford) 2007, 21:461-471.
190. O'Connell L.A., Hofmann H.A. The vertebrate mesolimbic reward system and social behaviour network: a comparative synthesis. Journal of Comparative Neurology 2011, 519:3599-3639.
191. ÖHman A. Face the beast and fear the face: animal and social fears as prototypes for evolutionary analyses of emotion. Psychophysiology 1986, 23:123-145.
192. Oitzl M.S., Schwabe L., Aggleton J.P. Memory formation: its changing face. Neuroscience & Biobehavioral Reviews 2012, 36:1577-1578.
193. Olds J., Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of Comparative and Physiological Psychology 1954, 47:419-427.
194. Oorschot M., Lataster T., Thewissen V., Lardinois M., van Os J., Delespaul P.A., Myin-Germeys I. Symptomatic remission in psychosis and real-life functioning. British Journal of Psychiatry 2012, 201:215-220.
195. Oreški I., Jakovljević M., Aukst-Margetić B., Orlić Z.C., Vuksan-Ćusa B. Comorbidity and multimorbidity in patients with schizophrenia and bipolar disorder: similarities and differencies. Psychiatria Danubina 2012, 24:80-85.
196. Osby U., Brandt L., Correia N., Ekbom A., Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Archives of General Psychiatry 2001, 58:844-850.
197. Oud M.J., Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Family Practice 2009, 10:32.
198. Owen D.R., Rupprecht R., Nutt D.J. Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety?. Journal of Psychopharmacology 2013, 27(2):119-122.
199. Papakostas G.I. Tolerability of modern antidepressants. The Journal of Clinical Psychiatry 2008, 69(Suppl. E1):8-13.
200. Park S.Q., Kahnt T., Beck A., Cohen M.X., Dolan R.J., Wrase J., Heinz A. Prefrontal cortex fails to learn from reward prediction errors in alcohol dependence. Journal of Neuroscience 2010, 30:7749-7753.
201. Passamonti L., Crockett M.J., Apergis-Schoute A.M., Clark L., Rowe J.B., Calder A.J., Robbins T.W. Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression. Biological Psychiatry 2012, 71:36-43.
202. Passingham R.E., Toni I., Rushworth M.F. Specialisation within the prefrontal cortex: the ventral prefrontal cortex and associative learning. Experimental Brain Research 2000, 133:103-113.
203. Pezawas L., Meyer-Lindenberg A., Goldman A.L., Verchinski B.A., Chen G., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry 2008, 13:709-716.
204. Pfaff D.W., Martin E.M., Ribeiro A.C. Relations between mechanisms of CNS arousal and mechanisms of stress. Stress 2007, 10:316-325.
205. Pitcher B.J., Harcourt R.G., Charrier I. Rapid onset of maternal vocal recognition in a colonially breeding mammal, the Australian sea lion. PLoS ONE 2010, 5:e12195.
206. Polman J.A.E., Hunter R.G., Speksnijder N., Oever J.M.E.v.d., Korobko O.B., McEwen B.S., de Kloet E.R., Datson N.A. Glucocorticoids modulate the mtor pathway in the hippocampus: differential effects depending on stress history. Endocrinology 2012, 153:4317-4327.
207. Porrino L.J., Lyons D., Smith H.R., Daunais J.B., Nader M.A. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. Journal of Neuroscience 2004, 24:3554-3562.
208. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M.R., Rahman A. No health without mental health. Lancet 2007, 370:859-877.
209. Puls I., Mohr J., Wrase J., Vollstädt-Klein S., Leménager T., Vollmert C., Rapp M., Obermayer K., Heinz A., Smolka M.N. A model comparison of COMT effects on central processing of affective stimuli. Neuroimage 2009, 46:683-691.
210. Radyushkin K., El-Kordi A., Boretius S., Castaneda S., Ronnenberg A., Reim K., Bickeboller H., Frahm J., Brose N., Ehrenreich H. Complexin2 null mutation requires a 'second hit' for induction of phenotypic changes relevant to schizophrenia. Genes, Brain and Behaviour 2010, 9:592-602.
211. Refojo D., Schweizer M., Kuehne C., Ehrenberg S., Thoeringer C., Vogl A.M., Dedic N., Schumacher M., von Wolff G., Avrabos C., Touma C., Engblom D., Schütz G., Nave K.A., Eder M., Wotjak C.T., Sillaber I., Holsboer F., Wurst W., Deussing J.M. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 2011, 333:1903-1907.
212. Riem M.M.E., Bakermans-Kranenburg M.J., Pieper S., Tops M., Boksem M.A.S., Vermeiren R.R.J.M., van IJzendoorn M.H., Rombouts S.A.R.B. Oxytocin modulates amygdala, insula and inferior frontal gyrus responses to infant crying: A randomized control trial. Biological Psychiatry 2011, 70:291-297.
213. Riem M.M.E., Bakermans-Kranenburg M.J., van IJzendoorn M.H., Out D., Rombouts S.A.R.B. Attachment in the brain: Adult attachment representations predict amygdala and behavioural responses to infant crying. Attachment & Human Development 2012, 14:533-551.
214. Ripke S., Wray N.R., Lewis C.M., Hamilton S.P., Weissman M.M., Breen G., Byrne E.M., Blackwood D.H., Boomsma D.I., Cichon S., Heath A.C., Holsboer F., Lucae S., Madden P.A., Martin N.G., McGuffin P., Muglia P., Noethen M.M., Penninx B.P., Pergadia M.L., Potash J.B., Rietschel M., Lin D., Müller-Myhsok B., Shi J., Steinberg S., Grabe H.J., Lichtenstein P., Magnusson P., Perlis R.H., Preisig M., Smoller J.W., Stefansson K., Uher R., Kutalik Z., Tansey K.E., Teumer A., Viktorin A., Barnes M.R., Bettecken T., Binder E.B., Breuer R., Castro V.M., Churchill S.E., Coryell W.H., Craddock N., Craig I.W., Czamara D., De Geus E.J., Degenhardt F., Farmer A.E., Fava M., Frank J., Gainer V.S., Gallagher P.J., Gordon S.D., Goryachev S., Gross M., Guipponi M., Henders A.K., Herms S., Hickie I.B., Hoefels S., Hoogendijk W., Hottenga J.J., Iosifescu D.V., Ising M., Jones I., Jones L., Jung-Ying T., Knowles J.A., Kohane I.S., Kohli M.A., Korszun A., Landen M., Lawson W.B., Lewis G., Macintyre D., Maier W., Mattheisen M., McGrath P.J., McIntosh A., McLean A., Middeldorp C.M., Middleton L., Montgomery G.M., Murphy S.N., Nauck M., Nolen W.A., Nyholt D.R., O'Donovan M., Oskarsson H., Pedersen N., Scheftner W.A., Schulz A., Schulze T.G., Shyn S.I., Sigurdsson E., Slager S.L., Smit J.H., Stefansson H., Steffens M., Thorgeirsson T., Tozzi F., Treutlein J., Uhr M., van den Oord E.J., Van Grootheest G., Völzke H., Weilburg J.B., Willemsen G., Zitman F.G., Neale B., Daly M., Levinson D.F., Sullivan P.F., (Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium) A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry 2013, 18:497-511.
215. Rizzolatti G., Fadiga L., Gallese V., Fogassi L. Premotor cortex and the recognition of motor actions. Cognitive Brain Research 1996, 3:131-141.
216. ROAMER-A Roadmap for Mental Health Research in Europe, (accessed 1.05.2013). Available from: http://www.roamer-mh.org.
217. Robbins T.W., Gillan C.M., Smith D.G., de Wit S., Ersche K.D. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends in Cognitive Sciences 2012, 16:81-91.
218. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews 1993, 18:247-291.
219. Robinson T.E., Berridge K.C. Incentive-sensitization and addiction. Addiction 2001, 96:103-114.
220. Robinson T.E., Berridge K.C. Addiction. Annual Review of Psychology 2003, 54:25-53.
221. Roelofs K., Minelli A., Mars R.B., van Peer J., Toni I. On the neural control of social emotional behaviour. Social Cognitive and Affective Neuroscience 2009, 4:50-58.
222. Rogers M.P., White K., Warshaw M.G., Yonkers K.A., Rodriguez-Villa F., Chang G., Keller M.B. Prevalence of medical illness in patients with anxiety disorders. International Journal of Psychiatry in Medicine 1994, 24:83-96.
223. Roitman M.F., Stuber G.D., Phillips P.E., Wightman R.M., Carelli R.M. Dopamine operates as a subsecond modulator of food seeking. Journal of Neuroscience 2004, 24:1265-1271.
224. Rossini P.M., Rossi S. Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential. Neurology 2007, 68:484-488.
225. Rummel-Kluge C., Komossa K., Schwarz S., Hunger H., Schmid F., Lobos C.A., Kissling W., Davis J.M., Leucht S. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophrenia Research 2010, 123:225-233.
226. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. American Journal of Psychiatry 2006, 163:1905-1917.
227. Rushworth M.F., Buckley M.J., Behrens T.E., Walton M.E., Bannerman D.M. Functional organisation of the medial frontal cortex. Current Opinion in Neurobiology 2007, 17:220-227.
228. Sanfey A.G. The neural basis of economic decision-making in the ultimatum game. Science 2003, 300:1755-1758.
229. Sapolsky R.M. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 2000, 21:55-89.
230. Sarabdjitsingh R.A., Isenia S., Polman A., Mijalkovic J., Lachize S., Datson N., de Kloet E.R., Meijer O.C. Disrupted corticosterone pulsatile patterns attenuate responsiveness to glucocorticoid signaling in rat brain. Endocrinology 2010, 151:1177-1186. http://www.ncbi.nlm.nih.gov/pubmed/20080870.
231. Sareen J., Cox B.J., Clara I., Asmundson G.J.G. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depression and Anxiety 2005, 21:193-202.
232. Schizophrenia Psychiatric Genome-Wide Association Study Consortium Genome-wide association study identifies five new schizophrenia loci. Nature Genetics 2011, 43:969-976.
233. Schuckit M.A. Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006, 101:76-88.
234. Schultz W. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
235. Schumann G., Coin L.J., Lourdusamy A., Charoen P., Berger K.H., Stacey D., Desrivières S., Aliev F.A., Khan A.A., Amin N., Aulchenko Y.S., Bakalkin G., Bakker S.J., Balkau B., Beulens J.W., Bilbao A., de Boer R.A., Beury D., Bots M.L., Breetvelt E.J., Cauchi S., Cavalcanti-Proença C., Chambers J.C., Clarke T.K., Dahmen N., de Geus E.J., Dick D., Ducci F., Easton A., Edenberg H.J., Esko T., Fernández-Medarde A., Foroud T., Freimer N.B., Girault J.A., Grobbee D.E., Guarrera S., Gudbjartsson D.F., Hartikainen A.L., Heath A.C., Hesselbrock V., Hofman A., Hottenga J.J., Isohanni M.K., Kaprio J., Khaw K.T., Kuehnel B., Laitinen J., Lobbens S., Luan J., Mangino M., Maroteaux M., Matullo G., McCarthy M.I., Mueller C., Navis G., Numans M.E., Núñez A., Nyholt D.R., Onland-Moret C.N., Oostra B.A., O'Reilly P.F., Palkovits M., Penninx B.W., Polidoro S., Pouta A., Prokopenko I., Ricceri F., Santos E., Smit J.H., Soranzo N., Song K., Sovio U., Stumvoll M., Surakk I., Thorgeirsson T.E., Thorsteinsdottir U., Troakes C., Tyrfingsson T., Tönjes A., Uiterwaal C.S., Uitterlinden A.G., van der Harst P., van der Schouw Y.T., Staehlin O., Vogelzangs N., Vollenweider P., Waeber G., Wareham N.J., Waterworth D.M., Whitfield J.B., Wichmann E.H., Willemsen G., Witteman J.C., Yuan X., Zhai G., Zhao J.H., Zhang W., Martin N.G., Metspalu A., Doering A., Scott J., Spector T.D., Loos R.J., Boomsma D.I., Mooser V., Peltonen L., Stefansson K., van Duijn C.M., Vineis P., Sommer W.H., Kooner J.S., Spanagel R., Heberlein U.A., Jarvelin M.R., Elliott P. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:7119-7124.
236. Schumann G., Loth E., Banaschewski T., Barbot A., Barker G., Buchel C., Conrod P.J., Dalley J.W., Flor H., Gallinat J., Garavan H., Heinz A., Itterman B., Lathrop M., Mallik C., Mann K., Martinot J.L., Paus T., Poline J.B., Robbins T.W., Rietschel M., Reed L., Smolka M., Spanagel R., Speiser C., Stephens D.N., Strohle A., Struve M., consortium I. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Molecular Psychiatry 2010, 15:1128-1139.
237. Schumann G., Loth E., Banaschewski T., Barbot A., Barker G., Büchel C., Conrod P.J., Dalley J.W., Flor H., Gallinat J., Garavan H., Heinz A., Itterman B., Lathrop M., Mallik C., Mann K., Martinot J.-L., Paus T., Poline J.-B., Robbins T.W., Rietschel M., Reed L., Smolka M., Spanagel R., Speiser C., Stephens D.N., Ströhle A., Struve M., IMAGEN consortium The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Molecular Psychiatry 2010, 15:1128-1139.
238. Schütze M., Boeing H., Pischon T., Rehm J., Kehoe T., Gmel G., Olsen A., Tjønneland A.M., Dahm C.C., Overvad K., Clavel-Chapelon F., Boutron-Ruault M.C., Trichopoulou A., Benetou V., Zylis D., Kaaks R., Rohrmann S., Palli D., Berrino F., Tumino R., Vineis P., Rodriguez L., Agudo A., Sánchez M.J., Dorronsoro M., Chirlaque M.D., Barricarte A., Peeters P.H., van Gils C.H., Khaw K.T., Wareham N., Allen N.E., Key T.J., Boffetta P., Slimani N., Jenab M., Romaguera D., Wark P.A., Riboli E., Bergmann M.M. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011, 342:d1584.
239. Senju A., Johnson M.H. The eye contact effect: mechanisms and development. Trends in Cognitive Sciences 2009, 13:127-134.
240. Senju A., Southgate V., White S., Frith U. Mindblind eyes: an absence of spontaneous theory of mind in asperger syndrome. Science 2009, 325:883-885.
241. Shin L., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010, 35:169-191.
242. Shiner T., Seymour B., Wunderlich K., Hill C., Bhatia K.P., Dayan P., Dolan R.J. Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease. Brain 2012, 135(6):1871-1883.
243. Singer T. The neuronal basis and ontogeny of empathy and mind reading: Review of literature and implications for future research. Neuroscience and Behavioural Reviews 2006, 30:855-863.
244. Smoller J.W., Craddock N., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., Ripke S., Santangelo S., Sullivan P.F., Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 20(381):1371-1379.
245. Soliman F., Glatt C.E., Bath K.G., Levita L., Jones R.M., Pattwell S.S., Jing D., Tottenham N., Amso D., Somerville L.H., Voss H.U., Glover G., Ballon D.J., Liston C., Teslovich T., van Kempen T., Lee F.S., Casey B.J. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010, 327:863-866.
246. Somerville L.H., Whalen P.J., Kelley W.M. Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biological Psychiatry 2010, 68:416-424.
247. Sonnby-Borgström M. Automatic mimicry reactions as related to differences in emotional empathy. Scandinavian Journal of Psychology 2002, 43(5):433-443.
248. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., Lascorz J., Depner M., Holzberg D., Soyka M., Schreiber S., Matsuda F., Lathrop M., Schumann G., Albrecht U. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nature Medicine 2005, 11:35-42.
249. Sporns O., Chialvo D., Kaiser M., Hilgetag C. Organisation, development and function of complex brain networks. Trends in Cognitive Sciences 2004, 8:418-425.
250. Stel M., van Knippenberg A. The role of facial mimicry in the recognition of affect. Psychological Science 2008, 19:984-985.
251. Stel M., Vonk R. Mimicry in social interaction: Benefits for mimickers, mimickees and their interaction. British Journal of Psychology 2010, 101:311-323.
252. Stephan K.E., Penny W.D., Daunizeau J., Moran R.J., Friston K.J. Bayesian model selection for group studies. Neuroimage 2009, 46:1004-1017.
253. Stewart A., Gaikwad S., Kyzar E., Green J., Roth A. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 2012, 62:135-143.
254. Strauss M.M., Makris N., Aharon I., Vangel M.G., Goodman J., Kennedy D.N., Gasic G.P., Breiter H.C. fMRI of sensitization to angry faces. Neuroimage 2005, 26:389-413.
255. Sullivan R.M., Holman P.J. Transitions in sensitive period attachment learning in infancy: the role of corticosterone. Neuroscience & Biobehavioral Reviews 2010, 34:835-844.
256. Tabarés-Seisdedos R., Gómez-Beneyto M., Haro J.M., González-Pinto A., Vieta E. The importance of negative comorbidity. Journal of Clinical Psychiatry 2009, 70:1191-1192. (author reply 1192).
257. Taylor D. Antipsychotic polypharmacy - confusion reigns. The Psychiatrist 2010, 34:41-43.
258. Taylor S.E. Inaugural article: mechanisms linking early life stress to adult health outcomes. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:8507-8512.
259. ten Velden Hegelstad W., Larsen T.K., Auestad B., Evensen J., Haahr U., Joa I., Johannesen J.O., Langeveld J., Melle I., Opjordsmoen S., Rossberg J.I., Rund B.R., Simonsen E., Sundet K., Vaglum P., Friis S., McGlashan T. Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. American Journal of Psychiatry 2012, 169:374-380.
260. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., Stacey S.N., Bergthorsson J.T., Thorlacius S., Gudmundsson J., Jonsson T., Jakobsdottir M., Saemundsdottir J., Olafsdottir O., Gudmundsson L.J., Bjornsdottir G., Kristjansson K., Skuladottir H., Isaksson H.J., Gudbjartsson T., Jones G.T., Mueller T., Gottsäter A., Flex A., Aben K.K., de Vegt F., Mulders P.F., Isla D., Vidal M.J., Asin L., Saez B., Murillo L., Blondal T., Kolbeinsson H., Stefansson J.G., Hansdottir I., Runarsdottir V., Pola R., Lindblad B., van Rij A.M., Dieplinger B., Haltmayer M., Mayordomo J.I., Kiemeney L.A., Matthiasson S.E., Oskarsson H., Tyrfingsson T., Gudbjartsson D.F., Gulcher J.R., Jonsson S., Thorsteinsdottir U., Kong A., Stefansson K. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-642.
261. Tiihonen J., Lönnqvist J., Wahlbeck K., Klaukka T., Niskanen L., Tanskanen A., Haukka J. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009, 374:620-627.
262. Tobacco Genetics Consortium Genome-wide meta-analyses identify multiple loci associated with smoking behaviour. Nature Genetics 2010, 42:441-447.
263. Tricklebank, M.D., Garner, J.P., The Possibilities and Limitations of Animal Models for Psychiatric Disorders, in: Rankovic, Z., Bingham, M., Nestler, E.J., Hargreaves, R. (Eds.), RSC Drug Discovery. Royal Society of Chemistry, Cambridge, pp. 534-557.
264. Umbricht D., Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophrenia Research 2005, 76:1-23.
265. van den Heuvel O.A., Mataix-Cols D., Zwitser G., Cath D.C., van der Werf Y.D., Groenewegen H.J., van Balkom A.J., Veltman D.J. Common limbic and frontal-striatal disturbances in patients with obsessive compulsive disorder, panic disorder and hypochondriasis. Psychological Medicine 2011, 41:2399-2410.
266. van der Kooij M.A., Sandi C. Social memories in rodents: methods, mechanisms and modulation by stress. Neuroscience & Biobehavioral Reviews 2012, 36:1763-1772.
267. van Praag H.M., de Kloet E.R., van Os J. Stress, the Brain and Depression 2004, Cambridge University Press, Cambridge. first ed.
268. Vieta E., Colom F. Therapeutic options in treatment-resistant depression. Annals of Medicine 2011, 43:512-530.
269. Vöhringer P.A., Ghaemi S.N. Solving the antidepressant efficacy question: effect sizes in major depressive disorder. Clinical Therapeutics 2011, 33:B49-B61.
270. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
271. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997, 386:827-830.
272. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr. Top. Behavioural Neuroscience 2012, 11:1-24.
273. Wacker J., Dillon D.G., Pizzagalli D.A. The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage 2009, 46:327-337.
274. Wang Y., Su Y., Fang P., Zhou Q. Facial expression recognition: can preschoolers with cochlear implants and hearing aids catch it?. Research In Developmental Disabilities 2011, 32:2583-2588.
275. Whelan R., Conrod P.J., Poline J.B., Lourdusamy A., Banaschewski T., Barker G.J., Bellgrove M.A., Büchel C., Byrne M., Cummins T.D., Fauth-Bühler M., Flor H., Gallinat J., Heinz A., Ittermann B., Mann K., Martinot J.L., Lalor E.C., Lathrop M., Loth E., Nees F., Paus T., Rietschel M., Smolka M.N., Spanagel R., Stephens D.N., Struve M., Thyreau B., Vollstaedt-Klein S., Robbins T.W., Schumann G., Garavan H., IMAGEN Consortium Adolescent impulsivity phenotypes characterised by distinct brain networks. Nature Neuroscience 2012, 15:920-925.
276. Wilke W.S., Gota C.E., Muzina D.J. Fibromyalgia and bipolar disorder: a potential problem?. Bipolar Disorder 2010, 12:514-520.
277. Williams G.V., Castner S.A. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 2006, 139:263-276.
278. Wittchen, H.-U., Knappe, S., Andersson, G., Araya, R., Banos Rivera, R. M., Barkham, M., Bech, P., Beckers, T., Berger, T., Berking, M., Berrocal, C, Botella, C., Carlbring, P., Chouinard, G., Csillag, C., Cujipers, P, David, D., Emmelkamp, P. M. G., Essau, C. A., Fava, G. A., Goschke, T., Hermans, D., Hofmann, S.G., Lutz, W., Muris, P., Ollendick, T. H., Raes, F., Rief, W., Riper, H., Tossani, E., van der Oord, S., Vervliet, B., Haro, J. M., Schumann, G. (2013, submitted) The psychological perspective on mental health and mental disorder research. Edited by H.-U. Wittchen & G. Schumann. International Journal of Methods in Psychiatric Research.
279. Wise R.A. Dopamine, learning and motivation. Nature Reviews Neuroscience 2004, 5:483-494.
280. Wyrwoll C.S., Holmes M.C., Seckl J.R. 11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Frontiers in Neuroendocrinology 2011, 32:265-286.
281. Ye T., Lipska B.K., Tao R., Hyde T.M., Wang L., Li C., Choi K.H., Straub R.E., Kleinman J.E., Weinberger D. Analysis of copy number variations in brain DNA from patients with schizophrenia and other psychiatric disorders. Biological Psychiatry 2012, 72:651-654.
282. Yehuda R., Seckl J. Stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. Endocrinology 2011, 152:4496-4503.
283. Yin H.H., Knowlton B.J., Balleine B.W. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. European Journal of Neuroscience 2004, 19:181-189.
284. Young A.M., Joseph M.H., Gray J.A. Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience 1993, 54:5-9.
285. Zalachoras I., Houtman R., Atucha E., Devos R., Tijssen A.M.I., Hu P., Lockey P.M., Datson N.A., Belanoff J.K., Lucassen P.J., Joëls M., de Kloet E.R., Roozendaal B., Hunt H., Meijer O.C. Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. Proceedings of the National Academy of Sciences of the United States of America 2013, (published ahead of print April 23, 2013). 10.1073/pnas.1219411110.